Sunday, March 30, 2025

Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease. 

from International: Top News And Analysis https://ift.tt/oFq0UMS

No comments:

Post a Comment

LightBlog